Drug details

Ubrelvy (ubrogepant tablets)

type of CGRP Receptor Antagonists

Ubrelvy (ubrogepant) is a calcitonin gene-related peptide receptor antagonist used for the acute treatment of migraine with or without aura in adults.

The drug is often used to treat Migraine .

This drug may have the following side effects:

• nausea,
• itching,
• rash,
• drowsiness,
• swelling of the face, tongue or throat,
• severe dizziness, and
• trouble breathing

The following drugs are related to Ubrelvy, either as a replacement or used together:

• Axert (almotriptan malate)
• Amerge (naratriptan)
• Fioricet with Codeine (butalbital acetaminophen caffeine capsules)
• Fioricet (butalbital and acetaminophen tablets)
• Fiorinal with Codeine (butalbital compound with codeine)
• Elyxyb (celecoxib oral solution)
• Relpax (eletriptan hydrobromide)
• Vyepti (eptinezumab-jjmr injection for intravenous use)
• Frova (frovatriptan succinate)
• Imitrex (sumatriptan succinate)
• Imitrex Injection (sumatriptan succinate injection)
• Imitrex Nasal Spray (sumatriptan nasal spray)
• Maxalt (rizatriptan benzoate)
• Nurtec ODT (rimegepant orally disintegrating tablets, for sublingual or oral use)
• RizaFilm (rizatriptan oral film)
• Zecuity (sumatriptan iontophoretic transdermal system)
• Zomig (zolmitriptan)
• Zomig Nasal Spray (zolmitriptan nasal spray)